OmniAb Research Development from 2010 to 2026

OABI Stock  USD 1.70  0.05  3.03%   
OmniAb's Research Development is increasing with slightly volatile movements from year to year. Research Development is predicted to flatten to about 43.5 M. For the period between 2010 and 2026, OmniAb, Research Development quarterly trend regression had mean deviation of  16,787,892 and range of 50.2 M. View All Fundamentals
 
Research Development  
First Reported
2020-09-30
Previous Quarter
10.9 M
Current Value
10.4 M
Quarterly Volatility
2.3 M
 
Covid
 
Interest Hikes
Check OmniAb financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among OmniAb's main balance sheet or income statement drivers, such as Net Interest Income of 3.8 M, Depreciation And Amortization of 18.5 M or Interest Expense of 708.8 K, as well as many indicators such as Price To Sales Ratio of 15.0, Dividend Yield of 0.0 or PTB Ratio of 1.38. OmniAb financial statements analysis is a perfect complement when working with OmniAb Valuation or Volatility modules.
  
Build AI portfolio with OmniAb Stock
Check out the analysis of OmniAb Correlation against competitors.
The Research Development trend for OmniAb Inc offers valuable insights into the company's financial trajectory and strategic direction. By examining multi-year patterns, investors can identify whether OmniAb is strengthening or weakening its position, and how this metric correlates with broader market conditions and industry benchmarks.

Latest OmniAb's Research Development Growth Pattern

Below is the plot of the Research Development of OmniAb Inc over the last few years. It is OmniAb's Research Development historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in OmniAb's overall financial position and show how it may be relating to other accounts over time.
Research Development10 Years Trend
Slightly volatile
   Research Development   
       Timeline  

OmniAb Research Development Regression Statistics

Arithmetic Mean27,233,917
Geometric Mean21,980,785
Coefficient Of Variation69.73
Mean Deviation16,787,892
Median13,208,000
Standard Deviation18,989,029
Sample Variance360.6T
Range50.2M
R-Value0.85
Mean Square Error107.1T
R-Squared0.72
Significance0.000016
Slope3,194,434
Total Sum of Squares5769.3T

OmniAb Research Development History

202643.5 M
202563.4 M
202455.1 M
202356.5 M
202248.4 M
202139.2 M
202024.8 M

About OmniAb Financial Statements

Investors use fundamental indicators, such as OmniAb's Research Development, to determine how well the company is positioned to perform in the future. Although OmniAb's investors may analyze each financial statement separately, they are all interrelated. Understanding these patterns can help investors make the right trading decisions.
Last ReportedProjected for Next Year
Research Development63.4 M43.5 M

Currently Active Assets on Macroaxis

When determining whether OmniAb Inc is a strong investment it is important to analyze OmniAb's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact OmniAb's future performance. For an informed investment choice regarding OmniAb Stock, refer to the following important reports:
Check out the analysis of OmniAb Correlation against competitors.
You can also try the ETFs module to find actively traded Exchange Traded Funds (ETF) from around the world.
Is there potential for Biotechnology market expansion? Will OmniAb introduce new products? Factors like these will boost the valuation of OmniAb. Anticipated expansion of OmniAb directly elevates investor willingness to pay premium valuations. Understanding fair value requires weighing current performance against future potential. All the valuation information about OmniAb listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(0.59)
Revenue Per Share
0.196
Quarterly Revenue Growth
(0.46)
Return On Assets
(0.13)
Return On Equity
(0.22)
OmniAb Inc's market price often diverges from its book value, the accounting figure shown on OmniAb's balance sheet. Smart investors calculate OmniAb's intrinsic value - its true economic worth - which may differ significantly from both market price and book value. Analysts utilize numerous techniques to assess fundamental value, seeking to purchase shares when trading prices fall beneath estimated intrinsic worth. Since OmniAb's trading price responds to investor sentiment, macroeconomic conditions, and market psychology, it can swing far from fundamental value.
It's important to distinguish between OmniAb's intrinsic value and market price, which are calculated using different methodologies. Investment decisions regarding OmniAb should consider multiple factors including financial performance, growth metrics, competitive position, and professional analysis. However, OmniAb's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.